Your browser doesn't support javascript.
loading
Nonadherence in Hypertension: How to Develop and Implement Chemical Adherence Testing.
Lane, Dan; Lawson, Alexander; Burns, Angela; Azizi, Michel; Burnier, Michel; Jones, Donald J L; Kably, Benjamin; Khunti, Kamlesh; Kreutz, Reinhold; Patel, Prashanth; Persu, Alexandre; Spiering, Wilko; Toennes, Stefan W; Tomaszewski, Maciej; Williams, Bryan; Gupta, Pankaj; Dasgupta, Indranil.
Afiliação
  • Lane D; The Department of Chemical Pathology and Metabolic Diseases, Level 4, Sandringham Building, Leicester Royal Infirmary, United Kingdom (D.L., P.P., P.G.).
  • Lawson A; Leicester Diabetes Centre, University of Leicester, Leicester General Hospital, Leicester, United Kingdom (D.L., K.K.).
  • Burns A; Department of Clinical Chemistry, Immunology and Toxicology, Heartlands Hospital University Hospitals Birmingham, United Kingdom (A.L.).
  • Azizi M; Department of Clinical Biochemistry, Queen Elizabeth University Hospital, Glasgow, United Kingdom (A.B.).
  • Burnier M; Université de Paris, Inserm CIC1418, Paris, France (M.A.).
  • Jones DJL; APHP, Hypertension Unit, Hôpital Européen Georges Pompidou, Paris, France (M.A.).
  • Kably B; Service of Nephrology and Hypertension, University Hospital, Lausanne, Switzerland (M.B.).
  • Khunti K; Department of Cardiovascular Sciences, University of Leicester, Cardiovascular Research Centre, Glenfield Hospital, Leicester, United Kingdom (D.J.L.J., P.P., P.G.).
  • Kreutz R; Université de Paris, France (B.K.).
  • Patel P; APHP, Pharmacology Unit, Hôpital Européen Georges Pompidou, Paris, France (B.K.).
  • Persu A; Leicester Diabetes Centre, University of Leicester, Leicester General Hospital, Leicester, United Kingdom (D.L., K.K.).
  • Spiering W; Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institut für Klinische Pharmakologie und Toxikologie, Germany (R.K.).
  • Toennes SW; The Department of Chemical Pathology and Metabolic Diseases, Level 4, Sandringham Building, Leicester Royal Infirmary, United Kingdom (D.L., P.P., P.G.).
  • Tomaszewski M; Department of Cardiovascular Sciences, University of Leicester, Cardiovascular Research Centre, Glenfield Hospital, Leicester, United Kingdom (D.J.L.J., P.P., P.G.).
  • Williams B; Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium/Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain (A.P.).
  • Gupta P; Department of Vascular Medicine, University Medical Center Utrecht, Utrecht University, the Netherlands (W.S.).
  • Dasgupta I; Institute of Legal Medicine, Department of Forensic Toxicology, University Hospital, Goethe University, Frankfurt, Germany (S.W.T.).
Hypertension ; 79(1): 12-23, 2022 01.
Article em En | MEDLINE | ID: mdl-34739765
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adesão à Medicação / Hipertensão / Anti-Hipertensivos Tipo de estudo: Guideline / Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Revista: Hypertension Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adesão à Medicação / Hipertensão / Anti-Hipertensivos Tipo de estudo: Guideline / Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Revista: Hypertension Ano de publicação: 2022 Tipo de documento: Article